SUMMIT THERAPEUTICS ANNOUNCES OPENING OF GLOBAL PHASE II STUDY OF IVONESCIMAB-BASED REGIMENS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA

Reuters · 2d ago

Please log in to view news